Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular antioxidant pathways encompass enzymatic and non-enzymatic defense mechanisms that maintain redox homeostasis by neutralizing reactive oxygen species (ROS) and other free radicals, thus preventing oxidative damage to DNA, proteins, and lipids. These pathways include the activity of key enzymes such as superoxide dismutases, catalase, glutathione peroxidase, and regulatory genes controlled by transcription factors like NRF2. Non-enzymatic antioxidants (such as glutathione, vitamins C and E) scavenge free radicals directly. Collectively, these systems modulate cell signaling, protect against cell death, and influence disease development—including cancer, cardiovascular disorders, and inflammation. Importantly, antioxidant therapy is context-dependent, and excessive intervention may impede normal cellular or immune function.
Free radical scavenging Upregulation of endogenous antioxidant enzymes (e.g., via NRF2 pathway) Augmentation of glutathione synthesis or recycling Protection of biomolecules from oxidation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular antioxidant pathway.